Member interest in PrEP policy and advocacy Survey

Thank you for taking the time to fill out this survey. HIVMA has heard from members interested in better engaging on issues around access to PrEP, coverage, and provider education. Your input here will help inform our advocacy to improve policies and reduce barriers to this effective intervention for your patients.

Please submit your responses by Friday November 9. Reach out with any questions or comments to HIVMA senior policy and advocacy manager, George Fistonich at gfistonich@hivma.org.

1.Name(Required.)

2.Email(Required.)

3.Institution/Affiliation(Required.)

4.How would you describe your practice affiliation setting that you primarily work in?(Required.)

Hospital or clinic

Private or group practice

University or medical school

Correctional facility

Other

5.Do you see HIV-negative patients who might benefit from PrEP for HIV prevention?(Required.)

Yes

6.Do you prescribe PrEP currently?(Required.)

Yes

7.If not, why are you not prescribing PrEP?

Limited provider capacity

Limited clinic space or capacity

Limited patient access to Truvada (tenofovir/emtricitabine)

No interest in prescribing PrEP

Other (please specify)

8.What do you see as the top 3 barriers to PrEP access in your community?

Perceived low HIV risk among patients

Inability to find a PrEP provider

State Medicaid is not covering it

Private insurers are not covering it

Cost sharing is too high for Truvada (tenofovir/emtricitabine)

Regular screening and monitoring requirements

Stigma

9.Is the cost of three site testing for chlamydia and gonorrhea a barrier to care?

Yes

10.What barriers do you encounter prescribing PrEP to adolescents?

Uninsured or other coverage issues

Privacy issues due to being on parent's insurance

Patients are not aware or interested

"PrEP is for adults only"

Other (please specify)

11.What educational resources would most help improve PrEP access?

Patient education for specific high-risk populations

Clinician webinars

In-person CME events

PrEP training at national conferences

Other (please specify)

12.How do you think we can better engage primary care and women's health providers to help expand PrEP access.

13.If an HIVMA PrEP affinity group was created, to meet by phone every 2-3 months to discuss clinical issues, access issues, policy recommendations, and ways to better educate other providers, would you be interested in participating?

Yes

Current Progress,

0 of 13 answered